Type Size

    Hypercalcemia, Hypercalciuria and Elevated Calcitriol Concentrations with Autosomal Dominant Transmission Due to CYP24A1 Mutations: Effects of Ketoconazole Therapy

    The CYP24A1 gene encodes the enzyme 1,25-dihydroxyvitamin D-24-hydroxylase, which inactivates, 1,25 dihydroxyvitamin D.  The authors describe a patient with intermittent hypercalcemia, hypercalciuria, elevated serum 1,25-dihydroxyvitamin D, undetectable serum 24,25-dihydroxyvitamin D, nephrolithiasis, and reduced bone mineral density, who had a mutation of CYP24A1.  When the patient was treated with the cytochrome 3A inhibitor, ketoconazole for 2 months, he demonstrated statistically significant reductions in urinary calcium, 1,25-dihydroxyvitamin D and serum calcium concentrations.


    Tebben PJ, Milliner DS, Horst RL, Harris PC, Singh RJ, Wu Y, et al

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Policies and Procedures for more details